These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19404847)

  • 1. Use of X-chromosome inactivation pattern and laser microdissection to determine the clonal origin of focal nodular hyperplasia of the liver.
    Gong L; Li YH; Su Q; Li G; Zhang WD; Zhang W
    Pathology; 2009; 41(4):348-55. PubMed ID: 19404847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma.
    Cai YR; Gong L; Teng XY; Zhang HT; Wang CF; Wei GL; Guo L; Ding F; Liu ZH; Pan QJ; Su Q
    World J Gastroenterol; 2009 Oct; 15(37):4695-708. PubMed ID: 19787833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes.
    Gong L; Li YH; Su Q; Chu X; Zhang W
    Histopathology; 2010 Apr; 56(5):589-99. PubMed ID: 20459569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonality and TP53 mutation analysis of focal nodular hyperplasia of the liver.
    Zheng S; Cummings OW; Saxena R; Zhang S; Wang M; Williamson SR; Cheng M; Lopez-Beltran A; Montironi R; Hodges KB; Cheng L
    Am J Clin Pathol; 2010 Jul; 134(1):65-70. PubMed ID: 20551268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal status of fibrous dysplasia.
    Gong L; Zhang W; Su Q
    Pathology; 2008 Jun; 40(4):392-5. PubMed ID: 18446630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
    Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
    J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver.
    Bioulac-Sage P; Rebouissou S; Sa Cunha A; Jeannot E; Lepreux S; Blanc JF; Blanché H; Le Bail B; Saric J; Laurent-Puig P; Balabaud C; Zucman-Rossi J
    Gastroenterology; 2005 May; 128(5):1211-8. PubMed ID: 15887105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of clonal status of pulmonary sclerosing hemangioma with X-chromosome inactivation mosaicism and polymorphism of phosphoglycerate kinase and androgen receptor genes.
    Gong L; Ren KX; Li YH; Liu XY; Zhang WD; Yao L; Zhu SJ; Han XJ; Zhang L; Lan M; Zhang W
    Med Oncol; 2011 Sep; 28(3):913-8. PubMed ID: 20422318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma associated with focal nodular hyperplasia. Report of a case with clonal analysis.
    Chen TC; Chou TB; Ng KF; Hsieh LL; Chou YH
    Virchows Arch; 2001 Apr; 438(4):408-11. PubMed ID: 11355178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma.
    Paradis V; Benzekri A; Dargère D; Bièche I; Laurendeau I; Vilgrain V; Belghiti J; Vidaud M; Degott C; Bedossa P
    Gastroenterology; 2004 May; 126(5):1323-9. PubMed ID: 15131793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
    Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
    Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation.
    Paradis V; Laurent A; Flejou JF; Vidaud M; Bedossa P
    Hepatology; 1997 Oct; 26(4):891-5. PubMed ID: 9328310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal nodular hyperplasia-like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation.
    Umetsu SE; Joseph NM; Cho SJ; Morotti R; Deshpande V; Jain D; Kakar S
    Hum Pathol; 2023 Dec; 142():20-26. PubMed ID: 37806391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
    Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
    AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization. Synchronous occurrence of focal nodular hyperplasia and hepatocellular carcinoma in the same liver is not based on common chromosomal aberrations.
    Kellner U; Jacobsen A; Kellner A; Mantke R; Roessner A; Röcken C
    Am J Clin Pathol; 2003 Feb; 119(2):265-71. PubMed ID: 12579998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.
    Rebouissou S; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2008 Jan; 48(1):163-70. PubMed ID: 17997499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [X-chromosome inactivation patterns of different tumor nodules in multiple leiomyomas of uterus].
    Diao XL; Su Q; Wang SF; Zhang W; Gong L; Liu J; Feng YM
    Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):308-13. PubMed ID: 14514373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal expansion in evolution of chronic hepatitis to hepatocellular carcinoma as seen at an X-chromosome locus.
    Ochiai T; Urata Y; Yamano T; Yamagishi H; Ashihara T
    Hepatology; 2000 Mar; 31(3):615-21. PubMed ID: 10706551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal nodular hyperplasia with concomitant hepatocellular carcinoma: a case report and clonal analysis.
    Zhang SH; Cong WM; Wu MC
    J Clin Pathol; 2004 May; 57(5):556-9. PubMed ID: 15113871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.
    Di Gioia S; Bianchi P; Destro A; Grizzi F; Malesci A; Laghi L; Levrero M; Morabito A; Roncalli M
    BMC Cancer; 2006 Apr; 6():89. PubMed ID: 16606445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.